GC-MS based metabolite profiling, antioxidant and antiurolithiatic properties of apple cider vinegar
- PMID: 37090488
- PMCID: PMC10116371
- DOI: 10.2144/fsoa-2023-0035
GC-MS based metabolite profiling, antioxidant and antiurolithiatic properties of apple cider vinegar
Abstract
Aim: To perform in vitro analysis of antioxidant and antiurolithiasis to carry out GC-MS-based metabolite profile.
Materials & methods: The effect of apple cider vinegar (ACV) in vitro, antioxidant and GC-MS analysis was evaluated. The antioxidant studies were performed. In vitro techniques included nucleation, aggregation and growth assay.
Results & conclusion: The presence of polyphenols, flavonoids, alkaloids and carbohydrates was shown. Concentrations from 5-30 μg/ml could dissolve calcium oxalate (p < 0.05) in vitro. The IC50 value of ACV in DPPH was found to be around 7 μg/ml and the IC50 value of the ACV in ABTS assay was around 9 μg/ml. Different phytocompounds were obtained from GC-MS analysis. ACV can be consumed to prevent kidney stones which seems helpful to the current therapy.
Keywords: DPPH; antioxidant; antiurolithiatic; apple cider vinegar; phytochemical constituents.
Plain language summary
Due to the modern lifestyle, urolithiasis continues to be a global medical burden and is getting worse every day and seems to have a very high recurrence rate. Urolithiasis can be managed with the pharmacotherapy of drugs and the usage of medicinal plants and nutraceuticals. The effect of apple juice products on urine physiology has been studied profoundly. The product thus obtained was examined for antioxidant assay using DPPH and in vitro antiurolithiasis activity. Apple cider vinegar (ACV) exhibited dose-dependent radical scavenging activity against free radicals. The ACV demonstrated a substantial suppression of the DPPH radical in the DPPH assay. ACV could be a potential source of a natural antioxidant drink based on in vitro, phytochemical and GC–MS analysis which was noteworthy and thus can be used as a therapeutic agent against bladder stones.
© 2023 Ankul S Singh.
Figures






Similar articles
-
The Efficacy of Apple Cider Vinegar at Different pH Values as an Antimicrobial Agent: An In Vitro Study.J Contemp Dent Pract. 2023 Oct 1;24(10):779-786. doi: 10.5005/jp-journals-10024-3581. J Contemp Dent Pract. 2023. PMID: 38152911
-
Anti-Anemic Effect of Antioxidant-Rich Apple Vinegar against Phenylhydrazine-Induced Hemolytic Anemia in Rats.Life (Basel). 2022 Feb 4;12(2):239. doi: 10.3390/life12020239. Life (Basel). 2022. PMID: 35207526 Free PMC article.
-
Ameliorative effects of apple cider vinegar on neurological complications via regulation of oxidative stress markers.J Food Biochem. 2020 Dec;44(12):e13504. doi: 10.1111/jfbc.13504. Epub 2020 Oct 20. J Food Biochem. 2020. PMID: 33084094
-
Mangosteen vinegar from Garcinia mangostana: quality improvement and antioxidant properties.Heliyon. 2022 Dec 13;8(12):e11943. doi: 10.1016/j.heliyon.2022.e11943. eCollection 2022 Dec. Heliyon. 2022. PMID: 36590574 Free PMC article.
-
The effect of apple cider vinegar on lipid profiles and glycemic parameters: a systematic review and meta-analysis of randomized clinical trials.BMC Complement Med Ther. 2021 Jun 29;21(1):179. doi: 10.1186/s12906-021-03351-w. BMC Complement Med Ther. 2021. PMID: 34187442 Free PMC article.
Cited by
-
Apple Cider Vinegar Powder Mitigates Liver Injury in High-Fat-Diet Mice via Gut Microbiota and Metabolome Remodeling.Nutrients. 2025 Jun 28;17(13):2157. doi: 10.3390/nu17132157. Nutrients. 2025. PMID: 40647261 Free PMC article.
-
Arthritis alleviation: unveiling the potential in Abrus precatorius macerated oil.Future Sci OA. 2024 May 15;10(1):FSO981. doi: 10.2144/fsoa-2023-0248. eCollection 2024. Future Sci OA. 2024. PMID: 38817355 Free PMC article.
References
-
- Singh P, Harris PC, Sas DJ, Lieske JC. The genetics of kidney stone disease and nephrocalcinosis. Nat. Rev. Nephrol. 18(4), 224–240 (2022). - PubMed
-
• Demonstrates the need for carrying out the study and its relevance to question.
-
- Abufaraj M, Al Karmi J, Yang L. Prevalence and trends of urolithiasis among adults. Curr. Opin. Urol. 32(4), 425–432 (2022). - PubMed
-
- Pfister RC, Dretler SP. Percutaneous chemolysis of renal calculi. Urol. Radiol. 6(1), 138–143 (1984). - PubMed
-
- Al-Mamari SA. Treatment of urolithiasis. 177–279 (2017). http://link.springer.com/10.1007/978-3-319-62437-2_11 - DOI
LinkOut - more resources
Full Text Sources
Miscellaneous